InvestmentPitch Media Video Discusses MindBio Therapeutics’ Commencement of MB22001 Phase 2 Clinical Trial in World’s First Take-Home Microdosing Study for Patients with Depression
VANCOUVER, British Columbia, Aug. 25, 2023 (GLOBE NEWSWIRE) — MindBio Therapeutics (CSE:MBIO) (FSE:WF6), an Australia-based…